Porras A, Santos E
Laboratory of Cellular and Molecular Biology, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Int J Obes Relat Metab Disord. 1996 Mar;20 Suppl 3:S43-51.
Insulin-induced differentiation of 3T3 L1 cells can be mimicked by expression of transfected ras oncogenes but is completely blocked by expression of dominant negative Ras mutants, demonstrating that Ras proteins mediate insulin signaling in these mammalian cells. In contrast, transfection of tyrosine kinase oncogenes including trk and src dose not result in adipocytic differentiation. Transfected raf-1 oncogenes induce partial adipocytic differentiation, while dominant negative raf mutants block partially the insulin-induced differentiation process. Exposure of 3T3 L1 cells to insulin results in formation of the active Ras-GTP complex without GAP tyrosine phosphorylation. Insulin treatment of untransfected 3T3 L1 cells also induced quick activation of cytosolic 42 kDa mitogen-activated protein kinase (MAPK) and a 90 kDa S6 kinase (RSK). The activation of these cytosolic serine-threonine kinases was also mimicked by Ras expression (in the absence of insulin) in the same cells transfected with inducible ras oncogenes. Furthermore, insulin-induced activation of MAPK and RSK could be blocked by expression of a transfected, inducible dominant negative Ras mutant (N17). These results indicate that Ras proteins are obligatory intermediates in the activation of cytosolic ERKs by insulin. Insulin treatment of 3T3 L1 cells or expression of transfected ras oncogenes resulted also in hyperphosphorylation of cellular Raf-1. Insulin-induced Raf hyperphosphorylation was inhibited by expression of an inducible, dominant negative Ras mutant (N17). Interestingly, however, expression of transfected raf oncogenes did not induce MAPK or RSK activation, and the insulin-induced activation of these kinases was not blocked by expression of transfected dominant negative raf mutants. These results suggest a functional dissociation between Raf-1 and MAPK/RSK activation in insulin/Ras signaling pathways leading to 3T3 L1 differentiation and are consistent with Raf-1 kinase acting in a parallel pathway to the MAPK/RSK pathway after Ras activation in these cells.
转染的ras癌基因的表达可模拟胰岛素诱导的3T3 L1细胞分化,但显性负性Ras突变体的表达可完全阻断该过程,这表明Ras蛋白在这些哺乳动物细胞中介导胰岛素信号传导。相比之下,转染包括trk和src在内的酪氨酸激酶癌基因不会导致脂肪细胞分化。转染的raf-1癌基因诱导部分脂肪细胞分化,而显性负性raf突变体则部分阻断胰岛素诱导的分化过程。将3T3 L1细胞暴露于胰岛素会导致形成无GAP酪氨酸磷酸化的活性Ras-GTP复合物。用胰岛素处理未转染的3T3 L1细胞也会诱导胞质42 kDa丝裂原活化蛋白激酶(MAPK)和90 kDa S6激酶(RSK)的快速激活。在转染了可诱导ras癌基因的相同细胞中,Ras表达(在无胰岛素的情况下)也可模拟这些胞质丝氨酸-苏氨酸激酶的激活。此外,转染的、可诱导的显性负性Ras突变体(N17)的表达可阻断胰岛素诱导的MAPK和RSK激活。这些结果表明,Ras蛋白是胰岛素激活胞质ERK的必需中间体。用胰岛素处理3T3 L1细胞或转染的ras癌基因的表达也会导致细胞Raf-1的过度磷酸化。可诱导的显性负性Ras突变体(N17)的表达可抑制胰岛素诱导的Raf过度磷酸化。然而,有趣的是,转染的raf癌基因的表达不会诱导MAPK或RSK激活,并且转染的显性负性raf突变体的表达也不会阻断胰岛素诱导的这些激酶的激活。这些结果表明,在导致3T3 L1分化的胰岛素/Ras信号通路中,Raf-1与MAPK/RSK激活之间存在功能解离,并且与这些细胞中Ras激活后Raf-1激酶在与MAPK/RSK途径平行的途径中起作用一致。